血型鑑定產業的全球市場，到2028年的預測

基本試劑和自動化的進步推動革命性變革並加速成長機會

這項研究概述了全球血型分型產業。由於社會意識增強、衛生基礎設施改善、政府措施和人均收入增加等因素，預計將顯著成長。鐮狀貧血、地中海貧血、淋巴瘤、白血病和血友病等血液相關疾病的盛行率不斷增加，也支持了血型檢測的發展。包括自動分析儀和抗球蛋白篩檢工具在內的技術進步徹底改變臨床結果並改善血液相容性。主要市場參與者優先考慮研發（R&D）投資，以提供創新設備、提高安全性、延長保存期限並推動產業成長。在這個競爭環境中，策略夥伴關係和聯盟變得越來越普遍，使產業參與企業能夠擴大其產品範圍並提高其全球影響力。

本研究依地區（北美、歐洲、亞太地區、世界其他地區）、測試類型（ABO 血液檢測和 Rh 分型、抗體篩檢、 HLA型檢測、抗原分型等）和最終用戶（醫院、血液檢測）分析資料。分析該行業的促進因素和限制因素，並確定相關人員和市場相關人員可以利用該行業變化帶來的成長機會。基準年為2023年，預測期間為2024年至2028年。

目錄

概述

• 成長策略

策略要務

• 為什麼成長越來越困難？
• The Strategic Imperative 8（TM）
• 關鍵策略要務對全球血型分型產業的影響
• 成長機會推動Growth Pipeline Engine（TM）

成長機會分析

• 調查範圍
• 考試類型細分
• 最終用戶細分

血型分型 - 概述

• 成長指標
• 生長促進因子
• 成長抑制因素
• 預測假設
• 收益預測
• 收益預測分析
• 依地區分類的收益預測
• 依地區分類的收益預測分析 - 北美
• 依地區分類的收益預測分析 - 歐洲
• 依地區分類的收益預測分析 - 亞太地區
• 依地區分類的收益預測分析 - 世界其他地區
• 收益預測，依檢查類型細分
• 收益預測，依最終用戶
• 收益預測，依最終用戶分析
• 價格趨勢與分析
• 主要定價策略，依參與者分類
• 預計影響定價的因素
• 全球血型分型產業 - 值得注意的活動
• 各國血型分型償付途徑
• 競爭環境

競爭格局

• 主要競爭對手/產業參與者
• 收益佔有率，依參與者分類
• 每家公司的產品系列分析 - 按關鍵參數分類的產業參與者的競爭基準化分析

特色企業

• 特色企業

成長機會宇宙

• 成長機會1：策略自動化整合徹底改變血型分型
• 成長機會2：遠端血型檢測解決方案以增強可及性
• 成長機會3：在服務欠缺地區擴大血型鑑定服務
• 成長機會4：與遠端保健平台合作提供綜合血型服務
• 成長機會概覽

下一步

Advancements in Essential Reagents and Automation are Driving Revolutionary Change and Boosting Growth Opportunities

This study provides an overview of the global blood group typing industry, which is expected to witness significant growth, driven by factors like increased public awareness, improved healthcare infrastructure, government initiatives, and rising per capita income. The increasing prevalence of diseases associated with blood, such as sickle cell anemia, thalassemia, lymphoma, leukemia, and hemophilia, is also supporting the growth of blood group typing. Technological advances, including automated analyzers and antiglobulin screening tools, are revolutionizing clinical outcomes and enhancing blood compatibility. Major market players are prioritizing research and development (R&D) investments to offer innovative devices, improve safety, enhance storage duration, and promote industry growth. Strategic partnerships and alliances are becoming more popular in this competitive environment, allowing industry participants to broaden their product offerings and improve their worldwide presence.

The study offers relevant forecasts for this industry by region (North America, Europe, Asia-Pacific, and the rest of the world), test type (ABO blood tests & Rh typing, antibody screening, HLA typing, antigen typing, and others), and end users (hospitals, blood banks, clinical laboratories, and others). It analyzes the factors driving and restraining this industry and identifies the growth opportunities emerging from the changes in this space for stakeholders and market players to leverage. The base year is 2023, and the forecast period is from 2024 to 2028.

Table of Contents

Summary

• Growth Imperatives

Strategic Imperatives

• Why is it Increasingly Difficult to Grow?
• The Strategic Imperative 8™
• The Impact of the Top 3 Strategic Imperatives on the Global Blood Group Typing Industry
• Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

• Scope of the Study
• Test Type Segmentation
• End-user Segmentation

Blood Group Typing-Overview

• Growth Metrics
• Growth Drivers
• Growth Restraints
• Forecast Assumptions
• Revenue Forecast
• Revenue Forecast Analysis
• Revenue Forecast by Region
• Revenue Forecast Analysis by Region-North America
• Revenue Forecast Analysis by Region-Europe
• Revenue Forecast Analysis by Region-Asia-Pacific
• Revenue Forecast Analysis by Region-RoW
• Revenue Forecast by Test Type Segment
• Revenue Forecast by End User
• Revenue Forecast by End User Analysis
• Pricing Trends and Analysis
• Key Pricing Strategies Adopted by Players
• Factors Expected to Influence Pricing
• Global Blood Group Typing Industry-Notable Activities
• Blood Group Typing Reimbursement Pathways by Country
• Competitive Environment

Competitive Landscape

• Key Competitors and Industry Players
• Revenue Share by Player
• Company Product Portfolio Analysis-Competitive Benchmarking of Industry Players by Key Parameter

Companies to Watch

• Companies to Watch

Growth Opportunity Universe

• Growth Opportunity 1: Strategic Automation Integration to Revolutionize Blood Group Testing
• Growth Opportunity 2: Remote Blood Group Testing Solutions for Enhanced Accessibility
• Growth Opportunity 3: Expansion of Blood Typing Services in Underserved Regions
• Growth Opportunity 4: Collaborations with Telehealth Platforms for Integrated Blood Group Services
• Growth Opportunity Summary

Next Steps

• Your Next Steps
• Why Frost, Why Now?
• List of Exhibits
• Legal Disclaimer